You are in:Home/Publications/Intratympanic Steroid Treatment in Otitis Media with Effusion Resistant to Conventional Therapy in Children

Assist. KHaled El Husseiny Mohamed Khedr :: Publications:

Title:
Intratympanic Steroid Treatment in Otitis Media with Effusion Resistant to Conventional Therapy in Children
Authors: Hossam Eldin Mohammed Abdelazeem, Khaled Elhusseiny Mohammed Khdr*, Mohammed Goda Elnems
Year: 2024
Keywords: Not Available
Journal: Not Available
Volume: Not Available
Issue: Not Available
Pages: Not Available
Publisher: Not Available
Local/International: Local
Paper Link: Not Available
Full paper KHaled El Husseiny Mohamed Khedr_pre 1 vol 96-July 2024- Semon Sameh.pdf
Supplementary materials Not Available
Abstract:

Background: Children's hearing impairment is primarily caused by otitis media with effusion (OME). OME may be linked to developmental delays, thus early and appropriate therapy of OME avoids hearing and speech impairment in children. Treatment is still a contentious topic, though. Objectives: We aimed to assess the efficacy of Intratympanic (IT) steroids for the management of OME resistant to traditional medical Therapy. Patients and methods: The study was conducted on 40 patients who had complaints of hearing loss and bilateral OME that resisted medical treatment lasting at least three months. Under general anesthesia, we performed myringotomy and ventilation tube (VT) was inserted bilaterally on each patient Then we injected steroid (.5 ml methylprednisolone 40 mg/mL) into the right middle ear. During the operation and in follow-up visits, once a week for three weeks in a row. Results: Resolved OME was 32 (80%) ears with ventilation tube (VT) alone and 38 (95%) ears with ventilation tube (VT) and steroid injection. This difference was significant (p = 0.043). As regard postoperative complication, tympanosclerosis was noted in 6 (15%) non-injected ears and one injected ear (2.5%) and the difference was statistically significant (p

Google ScholarAcdemia.eduResearch GateLinkedinFacebookTwitterGoogle PlusYoutubeWordpressInstagramMendeleyZoteroEvernoteORCIDScopus